FRI0614 Physician-patient interactions in african american patients with systemic lupus erythematosus

C. Drenkard, G. Bao, T. T. Lewis, B. F. Pobiner, J. Priest, S. S. Lim
2018 FRIDAY, 15 JUNE 2018   unpublished
contents have been discussed in a previous abstract. The survey was completed upon request and in the presence of the reference clinician throughout the last quarter of 2017. The survey assessed three areas: therapeutic and hygienic-dietetic adherence, the perception of personalized follow-up and overall practical utility. In parallel, the number of annual attacks of patients using ReumaApp-Gota and the relative annual reduction of the uric acid level in peripheral blood were determined. In the
more » ... determined. In the case of patients using ReumaApp-AR, the demand for unscheduled visits due to flares of RA and the relative reduction of DAS28 were evaluated. In both cases, their results were compared with cohorts of patients who had not used any of the applications (35 of the drop group and 29 of the AR group). Results: Users of ReumAPP-Gota: Improvement in adherence 25/65, personalized follow-up is perceived 56/65, has utility in day-to-day 52/65. Users of Reu-mAPP-AR: Improve adherence 31/35, personalized follow-up is perceived 30/35, has utility in day to day 29/35. The number of annual gout attacks in patients users of the APP was 1.32 OF 0.45 and that of non-users was 1.27 OF 0.52 (P=0.848), the relative annual reduction of patients with gout users of the APP was 36.6 OF 6.6 % and that of non-users 33.7 of 11.2% (P=0.106). The number of urgent visits in a year of patients with RA users of the APP was 0.55 of 0.12 and that of the nonusers group 0.83 of 0.29 (P<0.001). The relative reduction of the DAS28 of patients using the APP was 34.9 of 5.9% and of the non-users was 31 of 7.7% (P<0.025). Conclusions: Although the use of applications for smartphones seems to generate a greater sense of medical vigilance on the part of patients and is globally considered useful, its impact on the therapeutic adherence in patients with gout is low and is reflected in the objective results of reduction of plasma uric acid figures and the number of annual attacks. In the case of patients with RA the use of the application significantly reduces the need for urgent visits, most likely because it allows the clinician to contact the patient priorly when certain parameters entered exceed certain margins. But on the other hand the relative reduction of DAS28 may be due to the fact that patients not users of the application are usually older than those who accept its use.
doi:10.1136/annrheumdis-2018-eular.1210 fatcat:5muhdjzwgvfqze4pqhesqstnn4